Articole cu mandate pentru acces public - Nazila KamalyAflați mai multe
Nu sunt disponibile nicăieri: 2
Sericin grafted multifunctional curcumin loaded fluorinated graphene oxide nanomedicines with charge switching properties for effective cancer cell targeting
M Jahanshahi, E Kowsari, V Haddadi-Asl, M Khoobi, JH Lee, ...
International journal of pharmaceutics 572, 118791, 2019
Mandate: Danish Council for Independent Research
Ac2-26-nanoparticles induce resolution of intestinal inflammation and anastomotic healing via inhibition of NF-κB signaling in a model of perioperative colitis
S Reischl, JH Lee, JRE Miltschitzky, V Vieregge, RL Walter, V Twardy, ...
Inflammatory bowel diseases 27 (9), 1379-1393, 2021
Mandate: German Research Foundation
Disponibile undeva: 32
Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology
N Bertrand, J Wu, X Xu, N Kamaly, OC Farokhzad
Advanced drug delivery reviews 66, 2-25, 2014
Mandate: US National Institutes of Health, Canadian Institutes of Health Research
Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release
N Kamaly, B Yameen, J Wu, OC Farokhzad
Chemical reviews 116 (4), 2602-2663, 2016
Mandate: US National Institutes of Health
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
N Kamaly, Z Xiao, PM Valencia, AF Radovic-Moreno, OC Farokhzad
Chemical Society Reviews 41 (7), 2971-3010, 2012
Mandate: US National Institutes of Health
Self-assembled peptide-based nanostructures: Smart nanomaterials toward targeted drug delivery
N Habibi, N Kamaly, A Memic, H Shafiee
Nano today 11 (1), 41-60, 2016
Mandate: US National Institutes of Health
Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation
J Shi, Z Xiao, N Kamaly, OC Farokhzad
Accounts of chemical research 44 (10), 1123-1134, 2011
Mandate: US National Institutes of Health
Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle
MA Miller, S Gadde, C Pfirschke, C Engblom, MM Sprachman, RH Kohler, ...
Science translational medicine 7 (314), 314ra183-314ra183, 2015
Mandate: US National Institutes of Health, German Research Foundation
Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice
G Fredman, N Kamaly, S Spolitu, J Milton, D Ghorpade, R Chiasson, ...
Science translational medicine 7 (275), 275ra20-275ra20, 2015
Mandate: US National Institutes of Health, National Institute for Health Research, UK …
Annexin A1–containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair
G Leoni, PA Neumann, N Kamaly, M Quiros, H Nishio, HR Jones, ...
The Journal of clinical investigation 125 (3), 1215-1227, 2015
Mandate: US National Institutes of Health, German Research Foundation, UK …
Engineered nanomedicine for myeloma and bone microenvironment targeting
A Swami, MR Reagan, P Basto, Y Mishima, N Kamaly, S Glavey, S Zhang, ...
Proceedings of the National Academy of Sciences 111 (28), 10287-10292, 2014
Mandate: US National Institutes of Health, Canadian Institutes of Health Research
Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles
N Kamaly, G Fredman, M Subramanian, S Gadde, A Pesic, L Cheung, ...
Proceedings of the National Academy of Sciences 110 (16), 6506-6511, 2013
Mandate: US National Institutes of Health
Nanomedicines for renal disease: current status and future applications
N Kamaly, JC He, DA Ausiello, OC Farokhzad
Nature Reviews Nephrology 12 (12), 738-753, 2016
Mandate: US National Institutes of Health
Targeted interleukin-10 nanotherapeutics developed with a microfluidic chip enhance resolution of inflammation in advanced atherosclerosis
N Kamaly, G Fredman, JJR Fojas, M Subramanian, WII Choi, K Zepeda, ...
ACS nano 10 (5), 5280-5292, 2016
Mandate: US National Institutes of Health
CXCR4‐targeted and MMP‐responsive iron oxide nanoparticles for enhanced magnetic resonance imaging
J Gallo, N Kamaly, I Lavdas, E Stevens, QD Nguyen, ...
Angewandte Chemie International Edition 53 (36), 9550-9554, 2014
Mandate: Cancer Research UK, UK Engineering and Physical Sciences Research Council …
Development of multinuclear polymeric nanoparticles as robust protein nanocarriers
J Wu, N Kamaly, J Shi, L Zhao, Z Xiao, G Hollett, R John, S Ray, X Xu, ...
Angewandte Chemie International Edition 53 (34), 8975-8979, 2014
Mandate: US National Institutes of Health
Targeted nanoparticles for colorectal cancer
BA Cisterna, N Kamaly, WI Choi, A Tavakkoli, OC Farokhzad, C Vilos
Nanomedicine 11 (18), 2443-2456, 2016
Mandate: US National Institutes of Health
Targeted nanotherapeutics encapsulating liver X receptor agonist GW3965 enhance antiatherogenic effects without adverse effects on hepatic lipid metabolism in Ldlr−/− mice
M Yu, J Amengual, A Menon, N Kamaly, F Zhou, X Xu, PE Saw, SJ Lee, ...
Advanced healthcare materials 6 (20), 1700313, 2017
Mandate: US Department of Defense, US National Institutes of Health, American Heart …
Nanomedicines for endothelial disorders
BL Chung, MJ Toth, N Kamaly, YJ Sei, J Becraft, WJM Mulder, ZA Fayad, ...
Nano today 10 (6), 759-776, 2015
Mandate: US National Institutes of Health
Copper-free click—a promising tool for pre-targeted PET imaging
HL Evans, RL Slade, L Carroll, G Smith, QD Nguyen, L Iddon, N Kamaly, ...
Chemical Communications 48 (7), 991-993, 2012
Mandate: Cancer Research UK
Informațiile despre publicații și finanțare sunt alese automat de un program informatic